Hyperfine news
Hyperfine, Inc. (Nasdaq:HYPR), creator of Swoop®, the first FDA-cleared portable magnetic resonance imaging (MRI) system™, is proud to announce that Queen’s University and Kingston Health Sciences Centre are deploying a Swoop system as part of their health services benefit
Hyperfine, Inc. (Nasdaq: HYPR) (“Hyperfine”), creator of the first U.S. Food and Drug Administration (“FDA”) cleared portable magnetic resonance imaging (“MRI”)TM device, Swoop®, is proud to announce that M Health Fairview is deploying a Swoop system in the emergency room (ER), intensive care unit (ICU) and post anesthesia environments at M Health Fairview University of Minnesota Medical Center. The hospital is the first i
- Business combination results in over $160 million in gross cash proceeds to Hyperfine
- Funds to catalyze commercial expansion of the world’s first FDA-cleared portable MRI systemTM and additional organic growth initiatives
- Hyperfine to begin trading on Nasdaq under ticker “HYPR”
Hyperfine Inc., the groundbreaking medical device company that created Swoop®, the world’s first FDA-cleared portable MRI systemTM, today anno
Hyperfine Inc., creator of the first FDA-cleared portable magnetic resonance imaging (MRI) device, Swoop®, today announced a partnership with Raising Malawi, which built and co-operates Malawi’s only specialized pediatric hospital, the Mercy James Centre for Paediatric Surgery & Intensive Care (MJC). Raising Malawi and Hyperfine are partnering to highlight the important research made possible at MJC with Hyperfine&rs